nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—PCYT2—forebrain—attention deficit hyperactivity disorder	0.0365	0.067	CbGeAlD
Lamivudine—PCYT1A—cardiovascular system—attention deficit hyperactivity disorder	0.021	0.0386	CbGeAlD
Lamivudine—PCYT2—nervous system—attention deficit hyperactivity disorder	0.0198	0.0364	CbGeAlD
Lamivudine—PCYT2—central nervous system—attention deficit hyperactivity disorder	0.0191	0.035	CbGeAlD
Lamivudine—PGK1—nervous system—attention deficit hyperactivity disorder	0.017	0.0313	CbGeAlD
Lamivudine—NME1—forebrain—attention deficit hyperactivity disorder	0.0166	0.0305	CbGeAlD
Lamivudine—PGK1—central nervous system—attention deficit hyperactivity disorder	0.0164	0.0301	CbGeAlD
Lamivudine—PGK1—cerebellum—attention deficit hyperactivity disorder	0.016	0.0294	CbGeAlD
Lamivudine—CMPK1—forebrain—attention deficit hyperactivity disorder	0.016	0.0294	CbGeAlD
Lamivudine—PCYT2—brain—attention deficit hyperactivity disorder	0.0152	0.0278	CbGeAlD
Lamivudine—NT5C—nervous system—attention deficit hyperactivity disorder	0.0144	0.0264	CbGeAlD
Lamivudine—NME1—cardiovascular system—attention deficit hyperactivity disorder	0.0141	0.0258	CbGeAlD
Lamivudine—NT5C—central nervous system—attention deficit hyperactivity disorder	0.0139	0.0254	CbGeAlD
Lamivudine—CMPK1—cardiovascular system—attention deficit hyperactivity disorder	0.0136	0.0249	CbGeAlD
Lamivudine—NT5C—cerebellum—attention deficit hyperactivity disorder	0.0135	0.0248	CbGeAlD
Lamivudine—PCYT1A—nervous system—attention deficit hyperactivity disorder	0.0135	0.0248	CbGeAlD
Lamivudine—NME2—cardiovascular system—attention deficit hyperactivity disorder	0.0132	0.0243	CbGeAlD
Lamivudine—PGK1—brain—attention deficit hyperactivity disorder	0.013	0.0239	CbGeAlD
Lamivudine—PCYT1A—central nervous system—attention deficit hyperactivity disorder	0.013	0.0239	CbGeAlD
Lamivudine—NT5C—brain—attention deficit hyperactivity disorder	0.011	0.0202	CbGeAlD
Lamivudine—CMPK1—midbrain—attention deficit hyperactivity disorder	0.0106	0.0194	CbGeAlD
Lamivudine—PCYT1A—brain—attention deficit hyperactivity disorder	0.0103	0.0189	CbGeAlD
Lamivudine—NME1—nervous system—attention deficit hyperactivity disorder	0.00903	0.0166	CbGeAlD
Lamivudine—CMPK1—nervous system—attention deficit hyperactivity disorder	0.0087	0.016	CbGeAlD
Lamivudine—NME1—central nervous system—attention deficit hyperactivity disorder	0.00869	0.0159	CbGeAlD
Lamivudine—NME2—nervous system—attention deficit hyperactivity disorder	0.0085	0.0156	CbGeAlD
Lamivudine—NME1—cerebellum—attention deficit hyperactivity disorder	0.0085	0.0156	CbGeAlD
Lamivudine—CMPK1—central nervous system—attention deficit hyperactivity disorder	0.00838	0.0154	CbGeAlD
Lamivudine—CMPK1—cerebellum—attention deficit hyperactivity disorder	0.00819	0.015	CbGeAlD
Lamivudine—NME2—central nervous system—attention deficit hyperactivity disorder	0.00819	0.015	CbGeAlD
Lamivudine—NME2—cerebellum—attention deficit hyperactivity disorder	0.008	0.0147	CbGeAlD
Lamivudine—NME1—brain—attention deficit hyperactivity disorder	0.0069	0.0127	CbGeAlD
Lamivudine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00681	0.0125	CbGeAlD
Lamivudine—CMPK1—brain—attention deficit hyperactivity disorder	0.00665	0.0122	CbGeAlD
Lamivudine—NME2—brain—attention deficit hyperactivity disorder	0.0065	0.0119	CbGeAlD
Lamivudine—ABCC4—forebrain—attention deficit hyperactivity disorder	0.00631	0.0116	CbGeAlD
Lamivudine—DCK—midbrain—attention deficit hyperactivity disorder	0.00527	0.00967	CbGeAlD
Lamivudine—SLC22A6—brain—attention deficit hyperactivity disorder	0.00434	0.00796	CbGeAlD
Lamivudine—DCK—nervous system—attention deficit hyperactivity disorder	0.00433	0.00795	CbGeAlD
Lamivudine—DCK—central nervous system—attention deficit hyperactivity disorder	0.00417	0.00765	CbGeAlD
Lamivudine—ABCC3—nervous system—attention deficit hyperactivity disorder	0.00415	0.00761	CbGeAlD
Lamivudine—DCK—cerebellum—attention deficit hyperactivity disorder	0.00408	0.00748	CbGeAlD
Lamivudine—ABCC3—central nervous system—attention deficit hyperactivity disorder	0.00399	0.00733	CbGeAlD
Lamivudine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00369	0.00678	CbGeAlD
Lamivudine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.00356	0.00653	CbGeAlD
Lamivudine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.00353	0.00648	CbGeAlD
Lamivudine—ABCC4—nervous system—attention deficit hyperactivity disorder	0.00342	0.00628	CbGeAlD
Lamivudine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.0034	0.00624	CbGeAlD
Lamivudine—DCK—brain—attention deficit hyperactivity disorder	0.00331	0.00608	CbGeAlD
Lamivudine—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.0033	0.00605	CbGeAlD
Lamivudine—ABCC3—brain—attention deficit hyperactivity disorder	0.00317	0.00582	CbGeAlD
Lamivudine—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00294	0.00539	CbGeAlD
Lamivudine—SLC22A1—brain—attention deficit hyperactivity disorder	0.00282	0.00518	CbGeAlD
Lamivudine—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00275	0.00504	CbGeAlD
Lamivudine—SLC22A3—brain—attention deficit hyperactivity disorder	0.0027	0.00495	CbGeAlD
Lamivudine—ABCC4—brain—attention deficit hyperactivity disorder	0.00262	0.0048	CbGeAlD
Lamivudine—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00227	0.00417	CbGeAlD
Lamivudine—ABCC1—brain—attention deficit hyperactivity disorder	0.00223	0.00409	CbGeAlD
Lamivudine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0022	0.00403	CbGeAlD
Lamivudine—PGK1—Disease—STUB1—attention deficit hyperactivity disorder	0.00214	0.00469	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00213	0.00469	CbGpPWpGaD
Lamivudine—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00202	0.00443	CbGpPWpGaD
Lamivudine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00195	0.00429	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—EP300—attention deficit hyperactivity disorder	0.00193	0.00425	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00192	0.00421	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.00414	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.00414	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00188	0.00414	CbGpPWpGaD
Lamivudine—SLC22A1—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00188	0.00413	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00188	0.00413	CbGpPWpGaD
Lamivudine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00186	0.00341	CbGeAlD
Lamivudine—ABCG2—brain—attention deficit hyperactivity disorder	0.00185	0.00339	CbGeAlD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00177	0.0039	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00175	0.00385	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0016	0.00351	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00338	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00149	0.00327	CbGpPWpGaD
Lamivudine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00147	0.00322	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00145	0.00319	CbGpPWpGaD
Lamivudine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00145	0.00266	CbGeAlD
Lamivudine—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00144	0.00316	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00314	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00136	0.003	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00134	0.00295	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00131	0.00287	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0013	0.00286	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00129	0.00284	CbGpPWpGaD
Lamivudine—ABCC3—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00129	0.00284	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00128	0.00281	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00128	0.00281	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00128	0.00281	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00123	0.00271	CbGpPWpGaD
Lamivudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00122	0.00269	CbGpPWpGaD
Lamivudine—ABCC4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.00267	CbGpPWpGaD
Lamivudine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00119	0.00219	CbGeAlD
Lamivudine—CMPK1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00119	0.00261	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00119	0.00261	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00119	0.00261	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00119	0.00261	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00115	0.00253	CbGpPWpGaD
Lamivudine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00115	0.00211	CbGeAlD
Lamivudine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00114	0.00251	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00113	0.00249	CbGpPWpGaD
Lamivudine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00112	0.00206	CbGeAlD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00112	0.00246	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00107	0.00234	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00106	0.00233	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00106	0.00233	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00104	0.00229	CbGpPWpGaD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00104	0.00229	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00229	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00229	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00104	0.00229	CbGpPWpGaD
Lamivudine—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00102	0.00225	CbGpPWpGaD
Lamivudine—PGK1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00101	0.00222	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00099	0.00218	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00099	0.00218	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00099	0.00218	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00099	0.00218	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000986	0.00217	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000986	0.00217	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000973	0.00214	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00097	0.00213	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00097	0.00213	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000962	0.00211	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000955	0.0021	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000943	0.00207	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000932	0.00205	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000931	0.00205	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000929	0.00204	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000914	0.00201	CbGpPWpGaD
Lamivudine—ABCB1—brain—attention deficit hyperactivity disorder	0.000911	0.00167	CbGeAlD
Lamivudine—NME2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000902	0.00198	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000902	0.00198	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000902	0.00198	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000899	0.00198	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000897	0.00197	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000889	0.00195	CbGpPWpGaD
Lamivudine—NME2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000887	0.00195	CbGpPWpGaD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000886	0.00195	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000848	0.00186	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000827	0.00182	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000825	0.00181	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00082	0.0018	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000812	0.00178	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000807	0.00177	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000788	0.00173	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—COMT—attention deficit hyperactivity disorder	0.000788	0.00173	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000788	0.00173	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000788	0.00173	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000783	0.00172	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000783	0.00172	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000783	0.00172	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000782	0.00172	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000774	0.0017	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000771	0.00169	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000769	0.00169	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000759	0.00167	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000756	0.00166	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00075	0.00165	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000737	0.00162	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000722	0.00159	CbGpPWpGaD
Lamivudine—NME2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000721	0.00158	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000717	0.00158	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000687	0.00151	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000686	0.00151	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000685	0.00151	CbGpPWpGaD
Lamivudine—NME1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000683	0.0015	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000683	0.0015	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000679	0.00149	CbGpPWpGaD
Lamivudine—NME1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000672	0.00148	CbGpPWpGaD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000667	0.00146	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000642	0.00141	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000639	0.0014	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000638	0.0014	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000634	0.00139	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000625	0.00137	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000613	0.00135	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000597	0.00131	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000593	0.0013	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000591	0.0013	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000589	0.0013	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000583	0.00128	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000579	0.00127	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000575	0.00126	CbGpPWpGaD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000556	0.00122	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000549	0.00121	CbGpPWpGaD
Lamivudine—NME1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000546	0.0012	CbGpPWpGaD
Lamivudine—NME2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000546	0.0012	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000543	0.00119	CbGpPWpGaD
Lamivudine—NME2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000542	0.00119	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000539	0.00119	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000525	0.00115	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00052	0.00114	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000518	0.00114	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00049	0.00108	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00048	0.00106	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000469	0.00103	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000469	0.00103	CbGpPWpGaD
Lamivudine—DCK—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000461	0.00101	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00045	0.000989	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000447	0.000981	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000443	0.000975	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000443	0.000974	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000429	0.000943	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000429	0.000942	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000429	0.000942	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000423	0.000929	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000416	0.000915	CbGpPWpGaD
Lamivudine—NME1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000414	0.00091	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000414	0.00091	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000413	0.000908	CbGpPWpGaD
Lamivudine—NME1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000411	0.000903	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000394	0.000866	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000389	0.000855	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000375	0.000823	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000357	0.000784	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000339	0.000744	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—EP300—attention deficit hyperactivity disorder	0.000338	0.000743	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000338	0.000743	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000338	0.000743	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000331	0.000729	CbGpPWpGaD
Lamivudine—PGK1—Disease—EP300—attention deficit hyperactivity disorder	0.000329	0.000723	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000328	0.000721	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000324	0.000713	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000316	0.000696	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000309	0.000679	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000296	0.00065	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000296	0.00065	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000291	0.00064	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000285	0.000627	CbGpPWpGaD
Lamivudine—DCK—Metabolism—COMT—attention deficit hyperactivity disorder	0.000284	0.000624	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000282	0.000621	CbGpPWpGaD
Lamivudine—DCK—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000282	0.00062	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000276	0.000605	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000272	0.000598	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000272	0.000598	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000272	0.000597	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000271	0.000595	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000269	0.000591	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000268	0.000588	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000263	0.000578	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000256	0.000563	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000251	0.000551	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000249	0.000547	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000237	0.00052	CbGpPWpGaD
Lamivudine—NME2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000234	0.000515	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000225	0.000495	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000217	0.000478	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000213	0.000468	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000213	0.000468	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00021	0.000461	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.000455	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000203	0.000447	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000195	0.000428	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000188	0.000412	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000188	0.000412	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000186	0.000408	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000186	0.000408	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000185	0.000406	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000183	0.000401	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000179	0.000394	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000178	0.000391	CbGpPWpGaD
Lamivudine—NME1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000178	0.00039	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000173	0.00038	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000173	0.00038	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000172	0.000377	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00017	0.000374	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00017	0.000374	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00017	0.000373	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000165	0.000362	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000164	0.00036	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000164	0.00036	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000162	0.000357	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000159	0.000349	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000158	0.000348	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000154	0.000339	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00015	0.00033	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000148	0.000326	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.000323	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000143	0.000314	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000142	0.000311	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000141	0.00031	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000138	0.000304	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000132	0.000289	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000129	0.000284	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000128	0.000282	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000124	0.000273	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—attention deficit hyperactivity disorder	0.000122	0.000268	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000114	0.00025	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000113	0.000248	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000112	0.000247	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000112	0.000245	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000105	0.00023	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000104	0.000229	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000101	0.000223	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000101	0.000223	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.98e-05	0.000219	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.27e-05	0.000204	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.11e-05	0.000178	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.72e-05	0.00017	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	7.69e-05	0.000169	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—attention deficit hyperactivity disorder	7.07e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	6.61e-05	0.000145	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	6.14e-05	0.000135	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.1e-05	0.000134	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	5.54e-05	0.000122	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.87e-05	0.000107	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.82e-05	0.000106	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.49e-05	9.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.63e-05	5.79e-05	CbGpPWpGaD
